Low but Long-lasting Risk of Reversal of Seroconversion in Patients With Rheumatoid Arthritis Receiving Immunosuppressive Therapy

In patients who have resolved hepatitis B virus (HBV) infection, treatment of rheumatoid arthritis (RA) can result in reappearance of hepatitis B surface antigen (HBsAg), called reverse seroconversion. We investigated clinical features and outcomes of reverse seroconversion in patients who received immunosuppressant or biologic therapy for RA.

Source: Clinical Gastroenterology and Hepatology - March 19, 2020 Category: Gastroenterology Authors: Ming-Han Chen, Ming-Huang Chen, Chung-Tei Chou, Ming-Chih Hou, Chang-Youh Tsai, Yi-Hsiang Huang Source Type: research